UnitedHealth Group shares dropped as much as 7.5% in premarket trading Wednesday in New York, following a Guardian investigation that revealed the health insurer shelled out “Premium Dividend” and “Shared Savings” bonuses to nursing homes that reduced hospital transfers for sick residents.
The Guardian’s investigation is based on thousands of confidential corporate and patient records obtained through sources, public records requests, and court filings, along with interviews with nearly two dozen current and former UnitedHealth and nursing home employees, as well as two whistleblower declarations submitted to Congress.
Due to France’s drug trafficking crisis, a large majority of French are in favor of the army being deployed into disadvantaged neighborhoods in problematic neighborhoods in France, including 80 percent of women.
The World Bank announced that it will begin repaying its debts to Afghan companies. According to an official statement, the bank owes $50 million to logistics and construction companies in Afghanistan. These payments will be made to the companies in three phases. Continue reading “World Bank Reopens Kabul Office After Talks With Finance Ministry”
Israel has endorsed a new aid distribution framework in Gaza that places facial recognition technology at its center, triggering widespread alarm over privacy concerns. The system, still without external funding, would restrict food access to those who do not undergo biometric screening. Continue reading “Israel Proposes Gaza Aid Distribution Tied to Biometric Facial Recognition”
Regeneron Pharmaceuticals announced it has been “named the successful bidder” in the defunct 23andMe’s bankruptcy auction. It will acquire 23andMe’s core business lines—including Personal Genome Service, Total Health and Research Services, and Biobank—for $256 million.
New York-based Regeneron revealed that the $256 million deal to acquire 23andMe’s gigantic pool of genetic data (estimated to include 15 million people) will close by the third quarter of this year.